0.1952EUR-0.31%Mkt Cap: 13.17M $P/E: —Today
Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic pathophysiology, type 2 diabetes, and liver diseases. It also develops treatments for rare metabolic diseases and associated…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap13.17M $
Enterprise Value76.62M $
Revenue (TTM)8.32M $
Gross Profit4.33M $
Net Income (TTM)-14.85M $
Revenue/Share0.1565 USD
Last Price0.1952 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees5
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0012432516
Valuation
P/E (Trailing)—
P/E (Forward)0.21
PEG—
EV/EBITDA—
EV/Revenue9.21
P/S1.59
P/B-0.17
EPS (TTM)-0.26
EPS (Forward)0.92
52W Range
0.19261% of range0.4800
52W High0.4800 EUR
52W Low0.1926 EUR
Profitability
Gross Margin52.02%
Oper. Margin-89.97%
EBITDA Margin0.00%
Profit Margin-178.45%
ROE—
ROA-20.72%
Growth
Revenue Growth87.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.19M $
CapEx (TTM)—
FCF Margin-133.37%
FCF Yield-84.27%
Net Debt65.17M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.96
Current Ratio0.26
Quick Ratio0.23
Book Value/Sh-1.1430 EUR
Cash/Share0.0380 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.62.08M
Float—
Insiders5.73%
Institutions4.99%
Technical
SMA 500.2025 (-3.6%)
SMA 2000.2425 (-19.5%)
Beta1.28
S&P 52W Chg18.16%
Avg Vol (30d)159.48K
Avg Vol (10d)275.98K
Technical Indicators
RSI (14)41.0
MACD-0.0021
MACD Signal-0.0017
MACD Hist.-0.0004
BB Upper0.2080 EUR
BB Middle0.2012 EUR
BB Lower0.1944 EUR
BB Width6.74%
ATR (14)0.0057 EUR
Vol Ratio (20d)0.52x